LSV Asset Management Cuts Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

LSV Asset Management lowered its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 590,700 shares of the company’s stock after selling 26,100 shares during the period. LSV Asset Management owned about 1.19% of Prestige Consumer Healthcare worth $36,163,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Ariel Investments LLC boosted its holdings in Prestige Consumer Healthcare by 173.8% in the third quarter. Ariel Investments LLC now owns 2,534,786 shares of the company’s stock worth $144,964,000 after acquiring an additional 1,609,044 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Prestige Consumer Healthcare by 0.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,101,504 shares of the company’s stock worth $62,995,000 after purchasing an additional 8,661 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Prestige Consumer Healthcare by 19.1% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,087,821 shares of the company’s stock worth $62,213,000 after purchasing an additional 174,416 shares during the period. Northern Trust Corp lifted its holdings in shares of Prestige Consumer Healthcare by 3.9% during the third quarter. Northern Trust Corp now owns 724,358 shares of the company’s stock worth $41,426,000 after purchasing an additional 27,287 shares during the period. Finally, Jennison Associates LLC lifted its holdings in shares of Prestige Consumer Healthcare by 3.0% during the third quarter. Jennison Associates LLC now owns 477,821 shares of the company’s stock worth $27,327,000 after purchasing an additional 13,871 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $70.00 on Monday. The stock has a 50 day simple moving average of $71.12 and a 200-day simple moving average of $64.66. Prestige Consumer Healthcare Inc. has a 1-year low of $55.96 and a 1-year high of $75.31. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, February 8th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.04 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The firm had revenue of $282.74 million during the quarter, compared to the consensus estimate of $280.25 million. During the same period in the prior year, the company earned $1.04 EPS. The firm’s revenue was up 2.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current year.

Wall Street Analyst Weigh In

PBH has been the subject of a number of analyst reports. TheStreet raised Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. One analyst has rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $110.00.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 5,336 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total value of $368,184.00. Following the completion of the sale, the senior vice president now directly owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.